Bruce G. Redman
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers 35
- CAR-T cell therapy research 15
- Cutaneous Melanoma Detection and Management 11
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 18
- Pulmonary and Respiratory Medicine top 0.5%
- Renal cell carcinoma treatment 40
- Prostate Cancer Treatment and Research 13
- Immunology top 1%
- Immunotherapy and Immune Responses 22
- Molecular Biology top 2%
-
- Bladder and Urothelial Cancer Treatments 12
- Co-authors
- Robert J. MotzerBrian I. RiniM. Dror MichaelsonGeorge WildingDaniel J. GeorgeGary R. HudesCharles M. BaumKim Margolin
- Journals
- JAMA (1 paper)Journal of Clinical Oncology (45 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- United StatesCanadaChina
In The Last Decade
Bruce G. Redman
142 papers receiving 8.8k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Oncology 4.7k
- Cancer Research 1.8k
- Pulmonary and Respiratory Medicine 3.8k
- Immunology 2.1k
- Molecular Biology 3.4k
Countries citing papers authored by Bruce G. Redman
This map shows the geographic impact of Bruce G. Redman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce G. Redman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce G. Redman more than expected).
Fields of papers citing papers by Bruce G. Redman
This network shows the impact of papers produced by Bruce G. Redman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce G. Redman. The network helps show where Bruce G. Redman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bruce G. Redman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 129 | |
| 2 | 2018 | 48 | |
| 3 | 2016 | 1 | |
| 4 | Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trialbreakdown → | 2014 | 865 |
| 5 | 2014 | 9 | |
| 6 | 2011 | 17 | |
| 7 | 2009 | 151 | |
| 8 | Comparative efficacy of sunitinib administered on an intermittent or a continuous daily dosing schedule in metastatic renal cell carcinoma (mRCC) and gastrointestinal stromal tumor (GIST) patients predicted using population PK approaches | 2008 | 4 |
| 9 | Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinomabreakdown → | 2005 | 1304 |
| 10 | 2005 | 43 | |
| 11 | A phase I study of CNI-1493, an inhibitor of cytokine release, in combination with high-dose interleukin-2 in patients with renal cancer and melanoma. | 2001 | 34 |
| 12 | 2000 | 1 | |
| 13 | 2000 | 21 | |
| 14 | 1998 | 137 | |
| 15 | 1996 | 8 | |
| 16 | 1996 | 5 | |
| 17 | 1995 | 49 | |
| 18 | 1993 | 16 | |
| 19 | 1992 | 68 | |
| 20 | 1991 | 6 |
About Bruce G. Redman
Bruce G. Redman is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 143 papers that have together received 9.1k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (40 papers), Cancer Immunotherapy and Biomarkers (35 papers), Immunotherapy and Immune Responses (22 papers), Cancer Genomics and Diagnostics (18 papers), CAR-T cell therapy research (15 papers), Prostate Cancer Treatment and Research (13 papers), Bladder and Urothelial Cancer Treatments (12 papers) and Cutaneous Melanoma Detection and Management (11 papers). The work is most often cited by research in Oncology (4.7k citations), Cancer Research (1.8k citations) and Pulmonary and Respiratory Medicine (3.8k citations). Bruce G. Redman has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Robert J. Motzer, Brian I. Rini, M. Dror Michaelson, George Wilding, Daniel J. George, Gary R. Hudes, Charles M. Baum, Kim Margolin, Sindy T. Kim and Michelle S. Ginsberg. Their work appears in journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.